⚕ GalenOps CRO console
← 707 (USA)

707-1206

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 707 (USA) (Dr. Dubois) · consented 2013-10-28
Adverse events
8
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

moderate assessed 2026-08-18

Moderate BLOOD CREATINE PHOSPHOKINASE INCREASED — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-11-26 (study day 30.0); relationship: POSSIBLE

moderate assessed 2026-08-18

Moderate BLOOD CREATINE PHOSPHOKINASE INCREASED — outcome: RECOVERED/RESOLVED; onset 2013-11-26 (study day 30.0); relationship: POSSIBLE

moderate assessed 2026-08-18

Moderate CONJUNCTIVITIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-02-08 (study day 104.0); relationship: REMOTE

moderate assessed 2026-08-18

Moderate CONJUNCTIVITIS — outcome: RECOVERED/RESOLVED; onset 2014-02-08 (study day 104.0); relationship: REMOTE

mild assessed 2026-08-18

Mild POSTNASAL DRIP — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-12-03 (study day 37.0); relationship: NONE

mild assessed 2026-08-18

Mild POSTNASAL DRIP — outcome: RECOVERED/RESOLVED; onset 2013-12-03 (study day 37.0); relationship: NONE

mild assessed 2026-08-18

Mild SINUS ARRHYTHMIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-11-25 (study day 29.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild SINUS ARRHYTHMIA — outcome: RECOVERED/RESOLVED; onset 2013-11-25 (study day 29.0); relationship: POSSIBLE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.